About us

The TG Pharma Company was set in 2020 by Krzysztof Grzyliński, MD and Witold Tarkowski, MD, PhD. In Dr Tarkowski's ophthalmological practice, he encountered numerous cases of previously undiagnosed Demodex spp. mite infestation associated with chronic blepharitis and dry eye symptoms and invented the medicinal product to provide substantial relief for his patients.

Today, TG Pharma is engaged in pharmaceutical formulation development and non-clinical and clinical research planning for its flagship medicinal product - Demophta, aimed to be indicated in the chronic Demodex blepharitis treatment.